Table 2.
GRADE evidence profile for pain scores.
Quality assessment | No. of patients | Effect | Quality | Importance | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | TAP | Wl | Absolute (95% CI) | ||
Pain scores at rest at 1 h (measured with: VAS; better indicated by lower values) | |||||||||||
5 | Randomized trials | Serious1 | No serious inconsistency | No serious indirectness | Serious2 | Strong association3 | 143 | 141 | MD 0.32 lower (0.87 lower to 0.24 higher) | Moderate | Critical |
Pain scores at rest at 2 h (measured with: VAS; better indicated by lower values) | |||||||||||
5 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious4 | Strong association3 | 121 | 121 | MD 0.76 lower (1.22 to 0.31 lower) | High | Critical |
Pain scores at rest at 4 h (measured with: VAS; better indicated by lower values) | |||||||||||
3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious2 | None | 80 | 79 | MD 0.57 lower (1.11 to 0.03 lower) | Moderate | Critical |
Pain scores at rest at 6 h (measured with: VAS; better indicated by lower values) | |||||||||||
5 | Randomized trials | Serious5 | No serious inconsistency | No serious indirectness | Serious2 | Strong association3 | 146 | 151 | MD 0.87 lower (1.08 to 0.65 lower) | Moderate | Critical |
Pain scores at rest at 12 h (measured with: VAS; better indicated by lower values) | |||||||||||
4 | Randomized trials | Serious1 | No serious inconsistency | No serious indirectness | Serious | Strong association3 | 144 | 142 | MD 0.78 lower (0.91 to 0.65 lower) | Moderate | Critical |
Pain scores at rest at 24 h (measured with: VAS; better indicated by lower values) | |||||||||||
8 | Randomized trials | Serious6 | No serious inconsistency | No serious indirectness | Serious2 | Very strong association7 | 270 | 267 | MD 0.55 lower (0.73 to 0.37 lower) | High | Critical |
Pain scores during movement at 1 h (measured with: VAS; better indicated by lower values) | |||||||||||
2 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 41 | 44 | MD 1.04 lower (2.07 lower to 0 higher) | High | Critical |
Pain scores during movement at 2 h (measured with: VAS; better indicated by lower values) | |||||||||||
3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 61 | 64 | MD 1.47 lower (2.32 to 0.62 lower) | High | Critical |
Pain scores during movement at 4 h (measured with: VAS; better indicated by lower values) | |||||||||||
3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious5 | None | 62 | 65 | MD 0.65 lower (1.24 to 0.06 lower) | Moderate | Critical |
Pain scores during movement at 6 h (measured with: VAS; better indicated by lower values) | |||||||||||
3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious6 | None | 62 | 65 | MD 0.73 lower (1.23 to 0.24 lower) | Moderate | Critical |
Pain scores during movement at 24 h (measured with: VAS; better indicated by lower values) | |||||||||||
5 | Randomized trials | Serious6 | No serious inconsistency | No serious indirectness | Serious2 | Strong association3 | 119 | 122 | MD 0.85 lower (1.16 to 0.53 lower) | Moderate | Critical |
1One study did not mention the randomization method, and two studies did not mention how the blindness method was implemented.
2Some data were collected from charts by a measurement tool or converted by a formula.
3More than 200 patients were enrolled.
4One study did not mention the randomization method, and one study did not mention how the blindness method was implemented.
5Several studies did not mention the randomization and blindness methods.
6One study did not mention the randomization and blindness methods.
7More than 500 patients were enrolled.